$SBIG
springbig Holdings Inc

2021 Q2 Form 10-Q Financial Statement

#000114036121028318 Filed on August 16, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $0.00
YoY Change
Cost Of Revenue $1.870M
YoY Change
Gross Profit $3.940M
YoY Change
Gross Profit Margin
Selling, General & Admin $3.580M
YoY Change
% of Gross Profit 90.86%
Research & Development $1.810M
YoY Change
% of Gross Profit 45.94%
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit 0.0%
Operating Expenses $164.3K $0.00 $5.025K
YoY Change
Operating Profit -$164.3K $0.00 -$5.025K
YoY Change
Interest Expense $12.58K
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.733M $0.00 $0.00
YoY Change
Pretax Income $2.568M
YoY Change
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $2.568M $0.00 $0.00
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $51.37K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $790.0K
YoY Change
Cash & Equivalents $790.0K $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $415.9K
YoY Change
Inventory
Prepaid Expenses $415.9K
Receivables
Other Receivables
Total Short-Term Assets $1.206M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0M
YoY Change
Total Long-Term Assets $200.0M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.206M
Total Long-Term Assets $200.0M
Total Assets $201.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $104.7K
YoY Change
Accrued Expenses $108.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $212.7K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $25.40M
YoY Change
Total Long-Term Liabilities $25.40M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $212.7K
Total Long-Term Liabilities $25.40M
Total Liabilities $25.61M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $500.0K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$24.39M $0.00 $0.00
YoY Change
Total Liabilities & Shareholders Equity $201.2M
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $2.568M $0.00 $0.00
YoY Change
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$24.04K -$25.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $160.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 217.0K
YoY Change
NET CHANGE
Cash From Operating Activities -24.04K -25.00
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 217.0K
Net Change In Cash -24.04K 217.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$24.04K -$25.00
Capital Expenditures $160.0K
Free Cash Flow -$184.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001801602
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
tcac Period To Prior To The Completion Of Business Combination
PeriodToPriorToTheCompletionOfBusinessCombination
P2D
tcac Period To Redeem Public Shares If Business Combination Is Not Completed Within Initial Combination Period
PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
P10D
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2020Q4 us-gaap Cash
Cash
185752
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
415864
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1205866
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
17061155
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
19936
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
175086530
CY2021Q1 tcac Founder Shares Forfeited Value
FounderSharesForfeitedValue
0
CY2021Q1 tcac Reclassifications Of Permanent To Temporary Equity Value
ReclassificationsOfPermanentToTemporaryEquityValue
168043280
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2063176
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2021Q2 tcac Reclassifications Of Permanent To Temporary Equity Value
ReclassificationsOfPermanentToTemporaryEquityValue
2568270
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2568267
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000007
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
196000000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
tcac Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
166853030
tcac Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
0
tcac Change In Value Of Ordinary Shares Subject To Possible Redemption
ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption
3758520
tcac Change In Value Of Ordinary Shares Subject To Possible Redemption
ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-571078
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40049
dei Entity Registrant Name
EntityRegistrantName
TUATARA CAPITAL ACQUISITION CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
655 Third Avenue,
dei Entity Address Address Line2
EntityAddressAddressLine2
8th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
917
dei Local Phone Number
LocalPhoneNumber
460-7522
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 us-gaap Assets Current
AssetsCurrent
185752
CY2021Q2 us-gaap Deferred Costs
DeferredCosts
0
CY2020Q4 us-gaap Deferred Costs
DeferredCosts
417083
CY2021Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
200018363
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
0
CY2021Q2 us-gaap Assets
Assets
201224229
CY2020Q4 us-gaap Assets
Assets
602835
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
104672
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
0
CY2021Q2 us-gaap Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current
AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent
108000
CY2020Q4 us-gaap Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current
AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent
332899
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
212672
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
582899
CY2021Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
18400000
CY2021Q2 us-gaap Cash
Cash
790002
CY2021Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
170611550
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4499186
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24497
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
500027
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5064
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000007
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
19936
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
201224229
CY2020Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
602835
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
us-gaap Investment Income Interest
InvestmentIncomeInterest
18363
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1600000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
853386
tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
415864
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
104672
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
200000000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
250000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
574672
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
201175328
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
604250
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0
us-gaap Net Income Loss
NetIncomeLoss
0
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185752
us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2021Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
250000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2021Q2 tcac Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
7000000
CY2020Q4 tcac Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
0
CY2021Q2 us-gaap Liabilities
Liabilities
25612672
CY2020Q4 us-gaap Liabilities
Liabilities
582899
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
17061155
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
164308
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
0
us-gaap Operating Expenses
OperatingExpenses
259886
us-gaap Operating Expenses
OperatingExpenses
0
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-164308
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-259886
us-gaap Operating Income Loss
OperatingIncomeLoss
0
CY2021Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2720000
CY2020Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1600000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0
CY2021Q2 tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
CY2020Q2 tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
853386
tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
12575
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
18363
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2732575
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
764977
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2568267
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
0
us-gaap Net Income Loss
NetIncomeLoss
505091
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
tcac Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
108000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
790002
tcac Deferred Underwriting Fee Charged To Additional Paid In Capital
DeferredUnderwritingFeeChargedToAdditionalPaidInCapital
0
us-gaap Net Income Loss
NetIncomeLoss
0
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
0
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
0
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Net Income Loss
NetIncomeLoss
505091
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
tcac Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
0
tcac Deferred Underwriting Fee Charged To Additional Paid In Capital
DeferredUnderwritingFeeChargedToAdditionalPaidInCapital
7000000
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
200000000
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6000000
CY2021Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
11766856
CY2021Q1 tcac Underwriting Fees
UnderwritingFees
4000000
CY2021Q1 tcac Underwriting Fees Deferred
UnderwritingFeesDeferred
7000000
CY2021Q1 tcac Other Offering Costs
OtherOfferingCosts
766856
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
200000000
tcac Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10.00
tcac Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10.00
CY2021Q2 tcac Net Tangible Asset Threshold For Redeeming Public Shares
NetTangibleAssetThresholdForRedeemingPublicShares
5000001
tcac Percentage Of Public Shares That Can Be Redeemed Without Prior Consent
PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent
0.15
tcac Percentage Of Public Shares That Would Not Be Redeemed If Business Combination Is Not Completed Within Initial Combination Period
PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
1
tcac Period To Complete Business Combination From Closing Of Initial Public Offering
PeriodToCompleteBusinessCombinationFromClosingOfInitialPublicOffering
P24M
tcac Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10.00
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q2 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
11766856
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
10913470
tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
853386
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q1 tcac Option For Underwriters To Purchase Additional Units Term
OptionForUnderwritersToPurchaseAdditionalUnitsTerm
P45D
CY2021Q1 tcac Additional Units That Can Be Purchased To Cover Over Allotments
AdditionalUnitsThatCanBePurchasedToCoverOverAllotments
2625000
CY2021Q1 tcac Deferred Underwriting Commissions Per Unit
DeferredUnderwritingCommissionsPerUnit
0.35
CY2021Q1 tcac Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
17061155
tcac Stock Conversion Ratio
StockConversionRatio
1
CY2021Q2 tcac Stock Conversion As Converted Percentage
StockConversionAsConvertedPercentage
0.20
tcac Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
tcac Period To Exercise Warrants After Closing Of Initial Public Offering
PeriodToExerciseWarrantsAfterClosingOfInitialPublicOffering
P12M
tcac Period To File Registration Statement After Initial Business Combination
PeriodToFileRegistrationStatementAfterInitialBusinessCombination
P15D
tcac Period For Registration Statement To Become Effective
PeriodForRegistrationStatementToBecomeEffective
P60D
tcac Trading Day Period To Calculate Volume Weighted Average Trading Price Following Notice Of Redemption
TradingDayPeriodToCalculateVolumeWeightedAverageTradingPriceFollowingNoticeOfRedemption
P10D
CY2021Q2 tcac Class Of Warrant Or Right Threshold Trigger Price For Redemption
ClassOfWarrantOrRightThresholdTriggerPriceForRedemption
10.00

Files In Submission

Name View Source Status
0001140361-21-028318-index-headers.html Edgar Link pending
0001140361-21-028318-index.html Edgar Link pending
0001140361-21-028318.txt Edgar Link pending
0001140361-21-028318-xbrl.zip Edgar Link pending
brhc10027773_10q.htm Edgar Link pending
brhc10027773_10q_htm.xml Edgar Link completed
brhc10027773_ex31-1.htm Edgar Link pending
brhc10027773_ex31-2.htm Edgar Link pending
brhc10027773_ex32-1.htm Edgar Link pending
brhc10027773_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcac-20210630.xsd Edgar Link pending
tcac-20210630_cal.xml Edgar Link unprocessable
tcac-20210630_def.xml Edgar Link unprocessable
tcac-20210630_lab.xml Edgar Link unprocessable
tcac-20210630_pre.xml Edgar Link unprocessable